US › Healthcare

bioAffinity Technologies, Inc. (BIAF)

US · Healthcare · Diagnostics & Research

$0.55-7.87%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.4M
Revenue YoY
-27.1%
Net profit
$-3.6M
Profit YoY
-36.5%
EPS
$-0.81
Net margin
-268.6%

Key statistics

Market cap
$3.5M
Forward P/E
0.0
P/B
1.08
Book value
$0.81
EPS (TTM)
$-4.67
52-week high
$13.50
52-week low
$0.55
50-day MA
$1.07
200-day MA
$1.72
Beta
-1.05

Analyst view

Analysts rate bioAffinity Technologies, Inc. a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $6.00.

Shareholding

Insiders
1.85%
Institutions
5.41%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC0.88%
Geode Capital Management, LLC0.77%
J. Safra Sarasin Holding AG0.68%
Vanguard Fiduciary Trust Co0.49%
Schonfeld Strategic Advisors LLC0.39%
State Street Corp0.23%
Northern Trust Corp0.20%
UBS Group AG0.15%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for bioAffinity Technologies, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.